4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-014375
Chief Development Officer bought 2,946 shares at an average $3.41 ($10,034)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shemesh Shay Chief Development Officer | 2022-02-04 | Purchase | +2,100 | $3.38 | $7,098 | 1,178,769 | D: show line 1 in the form |
| Shemesh Shay Chief Development Officer | 2022-02-07 | Purchase | +846 | $3.47 | $2,936 | 1,179,615 | D: show line 2 in the form |
| Open-market purchases · 2,946 sh · avg $3.41 · $10,034 | |||||||
Loading xslF345X03/tm225864-2_4seq1.xml…